What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Pharma Industry News Incyte’s Opzelura delivers Phase 3b win in moderate adult atopic dermatitis patients Incyte’s Opzelura cream shows strong Phase 3b results in adults with moderate atopic dermatitis. Find out what this could mean for EU filings and future growth. bySrinathOctober 26, 2025